Patients having chronic granulomatous disease (CGD), which is caused by a deficiency in the NADPH-oxidase system of phagocytes, making them unable to produce reactive oxygen species, are at high risk having invasive aspergillosis (IA) or other fungal infection. This evidence concerns the gene FMO5 and chronic granulomatous disease.